HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.
Mutant Screening in Plants
Mutant Screening in Plants
Mutant screening is a technique used to identify plants with altered traits due to gene mutations. These mutations can occur naturally or be induced through mutagens like chemicals or radiation. Screening for mutants enables researchers to study gene functions and their roles in growth, development, and stress responses. For example, mutants with improved drought tolerance or resistance to pathogens can be isolated, providing valuable insights into the genes responsible for these traits. Mutant screening accelerates the development of crops with desirable characteristics, contributing to food security and sustainable agriculture.
Committee Members
Srinivasa Rao Mentreddy
Alabama A&M University, United States
Mohammad Babadoost
University of Illinois, United States
Valasia Iakovoglou
UNESCO chair Con-E-Ect, International Hellenic University, Greece GPB 2027 Speakers
Aparna B Gunjal
Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce
Bethune-Cookman University, United States
Hillary Jean Pierre
Department of Pharmaceutics, United States
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States